Helping Address Polypharmacy
The Polypharmacy Time Bomb: Why We Need a Second Pair of Eyes for the 80-Year-Old on 12 Meds
Mrs. Jones walks in with a shopping bag full of medications. In 15 minutes, you're expected to catch every interaction. This is the hidden crisis in elderly care.
Mrs. Jones, 82 years old
Presenting with acute UTI, shopping bag of medications in hand
Mrs. Jones has multiple comorbidities that require ongoing management. Her conditions include:
💊 Current Medications
12 medicationsIn this 15-minute consult, you must:
- Treat her acute UTI
- Review all 12 medications
- Check for drug interactions
- Consider renal function
- Update her care plan
- Address cognitive decline concerns
The Scale of the Problem
The scenario above plays out in GP clinics across Australia every single day. The fear of missing a dangerous drug to drug interaction, like combining an NSAID for arthritis with an ACE inhibitor or anticoagulant, keeps GPs awake at night. And it should. Each year, an estimated 250,000 Australians are hospitalised due to medication-related problems, with another 400,000 presenting to emergency departments. Up to half of these admissions are considered potentially preventable.1
Polypharmacy, defined as the concurrent use of five or more medications, is now commonplace among older Australians. In 2024, two million Australians were exposed to polypharmacy. Among those aged 75 and over, 40% are dispensed more than five medications concurrently, significantly higher than the OECD average of 32%. In residential aged care, the situation is even more pronounced, with 92% of residents experiencing polypharmacy and an average of 10 regular medicines prescribed per person.2
The Limitations of Human Memory
No one becomes a GP to memorise drug interaction tables. Yet the cognitive burden placed on clinicians to recall every contraindication, every caution, every dose adjustment for patients with renal impairment, is enormous. Guidelines change constantly. New warnings are issued for common drugs that have been prescribed for years, including recent shifts in SGLT2 inhibitor usage, new cautions for PPIs with long-term use, and updated advice on anticoagulation in elderly patients with falls risk.5
The problem isn't competence. Australian GPs are among the best trained in the world. The problem is that human memory was never designed to hold thousands of interaction possibilities and retrieve them flawlessly under time pressure. In a 15-minute consultation with Mrs. Jones, something will be missed, not through negligence, but through the mathematics of cognitive load.
Common Interactions in Elderly Patients
Click to explore real-world drug interactions that AI can flag in real-time during consultations
⚠️ Risk: Acute Kidney Injury
NSAIDs can reduce the antihypertensive effect of ACE inhibitors and, more critically, increase the risk of acute kidney injury, especially in elderly patients with already compromised renal function. The combination can precipitate a spiral of declining kidney function that may become irreversible.
⚠️ Risk: Gastrointestinal Bleeding
Concurrent use of NSAIDs with antiplatelet or anticoagulant therapy significantly increases the risk of serious gastrointestinal bleeding. Elderly patients are already at elevated risk due to age-related changes in gastric mucosa and increased likelihood of previous GI events.
⚠️ Risk: Lactic Acidosis
Metformin accumulation in patients with renal impairment can lead to rare but life-threatening lactic acidosis. In elderly patients, eGFR can decline rapidly due to acute illness (like Mrs. Jones's UTI), dehydration, or concurrent nephrotoxic medications. The dose needs constant reassessment.
⚠️ Risk: Serotonin Syndrome
Both sertraline (SSRI) and tramadol (weak opioid with serotonergic activity) increase serotonin. The combination can precipitate serotonin syndrome, particularly concerning in elderly patients who may not present with classic symptoms. Signs may be misattributed to other conditions.
⚠️ Risk: Cognitive Decline & Falls
Many common medications have anticholinergic properties. Some are obvious, such as bladder antimuscarinics, while others are less so, including certain antidepressants, antihistamines, and antiemetics. The cumulative anticholinergic burden increases the risk of cognitive impairment, confusion, and falls in elderly patients. Mrs. Jones already has mild cognitive impairment.
AI as the Clinical Safety Net
This is where "scribing" is not enough. We need "reasoning." Mon AI doesn't just transcribe medication lists. It analyses them in real-time, checking for interactions, flagging concerns, and prompting the questions that matter.
Real-Time Interaction Checking
As medications are documented, the AI cross-references against known interactions, adjusted for Australian guidelines and PBS constraints. It doesn't just flag interactions. It explains them.
Contextual Reasoning
When a change is made, such as "Stop Metformin", the AI asks why. Is renal function declining? Is there lactic acidosis risk? It prompts the documentation that protects both patient and practitioner.
Renal & Hepatic Adjustment
The AI factors in latest pathology results, flagging when doses need adjustment for declining organ function, a critical consideration in the elderly where eGFR can change rapidly.
Deprescribing Prompts
Beyond adding medications, the AI identifies candidates for deprescribing: medications that may no longer be indicated, or where risks now outweigh benefits in the context of the patient's current health status.
🤝 Polypharmacy is a Team Sport
Managing complex medication regimens requires collaboration. AI adds a layer of safety that catches what human memory cannot.
See How Mon AI Handles Complex Medication Lists
For the growing population of elderly Australians with complex comorbidities, AI isn't about speed. It's about safety. Discover how real-time interaction checking can support your clinical decision-making.
Explore the Safety FeaturesBuilt for Australian healthcare. Aligned with PBS, eTG, and local guidelines.